The Business Research Company The Business Research Company's At-Home Genetic Testing Market Analysis 2025 – Insights For Long-Term Investm ...

Spartanburg Regional Healthcare System (SRHS) in the US has chosen AccessDx Laboratory as its partner for a pharmacogenomics ...

A major new study launching in Scotland aims to show how a simple genetic test could help doctors personalise treatments – ...

We surveyed 488 primary care providers in community and academic practices in New York City in the period 2014–16 about their views on genetic testing for chronic diseases. The majority of the ...

Pharmacogenetic (PGx) testing involves the analysis of genes known to affect response to medications. The field has been projected as a leading application of personalized or precision medicine ...

This study of oncology pharmacogenetic biomarker adoption is primarily limited to the investigation of factors associated with test adoption, not to factors related to the 'end-of-life cycle'.

Application of a Pharmacogenetic Test Adoption Model to Six Oncology Biomarkers Hawazin Faruki; Myla Lai-Goldman Disclosures Personalized Medicine. 2010;7 (4):441-450. 0 ...

The two most common strategies to test a pharmacogenetic question are the candidate-gene approach and genomewide association study. Given the complex interplay among the many factors that influence a ...

Finding the right antidepressant early in treatment may improve response rates, reduce time wasted on trial and error, and reduce the rates of recurrences.

The Moratorium on Genetic Testing and Insurance, developed by the Ministry of Health and the Life Insurance Association, ...

Chicago-based AI-genomics leader introduces its pioneering GeneCancer™ and GenePGx™ tests to the European market, starting ...